XML 20 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Revenues      
Product sales, net $ 1,501 $ 2,269 $ 6,291
Royalty revenue 10,543 9,682 2,386
Collaborative and other research and development 13,142 14,402 39,580
Total revenues 25,186 26,353 48,257
Expenses      
Cost of products sold 1,142 2,297 1,368
Research and development 66,962 61,008 72,758
Selling, general and administrative 13,933 11,253 13,047
Royalty 560 402 528
Total operating expenses 82,597 74,960 87,701
Loss from operations (57,411) (48,607) (39,444)
Interest and other income 1,015 793 535
Interest expense (8,565) (6,487) (5,200)
(Loss) gain on foreign currency derivative (821) (843) 1,090
Net loss $ (65,782) $ (55,144) $ (43,019)
Basic and diluted net loss per common share (in dollars per share) $ (0.78) $ (0.75) $ (0.59)
Weighted average shares outstanding (in shares) 84,451 73,699 72,901
Unrealized (loss) gain on available for sale investments $ (231) $ 194 $ (76)
Comprehensive loss $ (66,013) $ (54,950) $ (43,095)